News

Around 316 healthy adults aged 18-40 were enrolled in the Phase I trial and they were each evaluated for vaccine tolerability and immune response at 21 days post-vaccination.

The Israeli firm is a developer, manufacturer and marketer of new bio-active lipid based nutritional ingredients and medical foods. Around 171 patients between the ages of 18 and

As part of the deal, BioAtla will direct BioDuro’s efforts to advance these compounds through the preclinical and Phase I clinical phases and each candidate will be licensed

Stellar is a manufacturer of KLH, an immune-stimulating protein widely used as a carrier molecule in the development of immunotherapies. Spain-based Araclon is majority-owned by global healthcare firm

Under the deal, Takeda will use GE’s diagnostic imaging technology to noninvasively map the hardening of liver tissue. Combining the strengths of the two companies, the collaboration is

The two firms aim to exploit business opportunities in the Chinese market for new drugs. Under the deal, ScinoPharm will be responsible for the development and manufacturing of

Selinexor works by inhibiting the nuclear export protein XPO1, leading to the accumulation of tumor suppressor proteins in the cell nucleus, which subsequently reinitiates and amplifies their tumor

Dixon Marketing is a highly respected leader in the military marketplace and will help KonaRed to bring its products to the military market. KonaRed’s CEO Shaun Roberts stated,

The partnership provides clinical and pathology laboratories that have adopted Cartagenia’s Bench for Oncology software platform for their genetic sequencing analysis and reporting workflow with the option to